Gynofem Healthcare and Pharmaceuticals Limited Unlisted Shares - Company Overview

Gynofem Healthcare and Pharmaceuticals Limited is an unlisted public company incorporated on 13 October, 2022. It is classified as a public limited company and is located in Indore, Madhya Pradesh. Its authorized share capital is INR 10.00 cr and the total paid-up capital is INR 9.92 cr.

It is classified as non-govt company and is registered at Registrar of Companies, Gwalior. Gynofem Healthcare and Pharmaceuticals Limited's Corporate Identification Number is (CIN) U24290MP2022PLC063077 and its registration number is 63077.Its Email address is gynofempharmaltd@gmail.com and its registered address is 75/2/16, S K Compound, Lasudiya Mori Dewas Naka Indore MP 452010 IN. Directors of Gynofem Healthcare and Pharmaceuticals Limited are Nishi Kant Joshi, Anurag Mendhe and Kartikay Joshi.

Gynofem Healthcare and Pharmaceuticals Limited Share Price, Share Details as of March 31, 2025

Gynofem Healthcare and Pharmaceuticals Limited Incorporation Details

Gynofem Healthcare and Pharmaceuticals Limited Board of Directors

Gynofem Healthcare and Pharmaceuticals Limited Shareholding Pattern (as on 31-03-2025)

Category	No. of Shares	% Of Shares held
Promoters	7,92,13,898	79.84%
Public Shareholding	2,00,00,000	20.16%
Total	9,92,13,898	100.00%

Gynofem Healthcare and Pharmaceuticals Ltd Principal Business Activities

FAQ's on Gynofem Healthcare 

Q: What is the face value of Gynofem Healthcare Ltd shares?
Answer: The face value of Gynofem Healthcare Ltd is ₹1 per equity share.

Q: What is the minimum lot size for buying Gynofem Healthcare shares through WWIPL?
Answer: The minimum lot size for Gynofem Healthcare shares is 1000 equity shares.

Q: How can I buy Gynofem Healthcare unlisted shares through WWIPL?
Answer: Investors can complete KYC, confirm the transaction details with WWIPL, transfer funds, and receive shares directly in their Demat account.

Q: Why should I buy Gynofem Healthcare shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.

Q: Is investing in Gynofem Healthcare Ltd a good idea?
Answer: Investors often evaluate Gynofem Healthcare based on its presence in the women's healthcare segment, product portfolio, regulatory compliance, and long-term growth prospects.

Q: Why do investors buy Gynofem Healthcare shares before a potential IPO?
Answer: Investors seek early exposure to a specialized healthcare company before a potential listing, aiming to participate in future value creation and liquidity opportunities.

Q: What business does Gynofem Healthcare Ltd operate in?
Answer: Gynofem Healthcare is engaged in the development, manufacturing, and marketing of pharmaceutical and healthcare products, with a focus on women's healthcare and gynecology.

Q: What makes Gynofem Healthcare different from other unlisted pharmaceutical companies?
Answer: The company specializes in women's healthcare, offering products across gynecology, obstetrics, fertility, and related therapeutic segments.

Q: What are the key growth drivers for Gynofem Healthcare Ltd?
Answer: Increasing healthcare awareness, rising demand for women's healthcare products, product launches, wider distribution, and growth in the pharmaceutical sector are key growth drivers.

Q: What factors affect the valuation of Gynofem Healthcare shares?
Answer: Revenue growth, product portfolio expansion, regulatory approvals, operating margins, profitability, and market penetration influence the company's valuation.

Q: Are Gynofem Healthcare shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.

Q: Can I sell my Gynofem Healthcare shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and availability.

Q: What documents are required to buy Gynofem Healthcare shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.

Q: What are the risks of investing in Gynofem Healthcare shares?
Answer: Investors should consider regulatory risks, competition, pricing pressures, product approval timelines, and liquidity constraints associated with unlisted shares.

Q: How does WWIPL help investors track Gynofem Healthcare investments?
Answer: WWIPL provides company updates, transaction assistance, market insights, and investment support to help investors stay informed.

Q: How long does it take for Gynofem Healthcare shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.

Q: What should investors evaluate before investing in Gynofem Healthcare Ltd?
Answer: Investors should assess the company's financial performance, product portfolio, regulatory compliance, profitability, valuation, and long-term growth prospects.

Q: Can Gynofem Healthcare benefit from the growth of India's healthcare and pharmaceutical sectors?
Answer: Yes. Rising healthcare expenditure, greater focus on women's health, and increasing demand for specialized pharmaceutical products may support the company's long-term growth.